Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G M Stern

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990
Diurnal differences in response to oral levodopaJ P Frankel, Z Pirtosek, P A Kempster, et al.
Lancet (London, England)|June 24, 1989
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468R Kapoon, Z Pirtosek, J P Frankel, et al.
Clinical Neuropharmacology|October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's diseaseJ P Frankel, P A Kempster, C M Stibe, et al.
Advances in Neurology|January 1, 1990
Effects of L-deprenyl on parkinsonian bradyphreniaV M Eatough, P A Kempster, J P Frankel, et al.
Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.
Lancet (London, England)|December 24, 1988
Role of subcutaneous apomorphine in parkinsonian voiding dysfunctionT J Christmas, P A Kempster, C R Chapple, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1989
Sublingual apomorphine and Parkinson's diseaseA J Lees, J L Montastruc, N Turjanski, et al.
Archives of Neurology|October 1, 1989
Anal sphincter dysfunction in Parkinson's diseaseS E Mathers, P A Kempster, P J Law, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1990
Diurnal differences in response to oral levodopaJ P Frankel, Z Pirtosek, P A Kempster, et al.
Lancet (London, England)|June 24, 1989
Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468R Kapoon, Z Pirtosek, J P Frankel, et al.
Clinical Neuropharmacology|October 1, 1989
A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's diseaseJ P Frankel, P A Kempster, C M Stibe, et al.
Advances in Neurology|January 1, 1990
Effects of L-deprenyl on parkinsonian bradyphreniaV M Eatough, P A Kempster, J P Frankel, et al.
Lancet (London, England)|October 15, 1977
Deprenyl in Parkinson's diseaseA J Lees, K M Shaw, L J Kohout, et al.
Lancet (London, England)|December 24, 1988
Role of subcutaneous apomorphine in parkinsonian voiding dysfunctionT J Christmas, P A Kempster, C R Chapple, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1989
Sublingual apomorphine and Parkinson's diseaseA J Lees, J L Montastruc, N Turjanski, et al.
Archives of Neurology|October 1, 1989
Anal sphincter dysfunction in Parkinson's diseaseS E Mathers, P A Kempster, P J Law, et al.
Psychopharmacology|April 14, 1978
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'J D Elsworth, V Glover, G P Reynolds, et al.
Pageof 14